
Millendo Therapeutics
closedAtterocor focuses on research and development of therapeutics for adrenal disease.
Employees
Enterprise value
$120—180m
Company register number
497575621
Recent deals
Authorizing premium user...
Atterocor focuses on research and development of therapeutics for adrenal disease.